Literature DB >> 11022080

Selective effects of subarachnoid hemorrhage on cerebral vascular responses to 4-aminopyridine in rats.

L Quan1, C G Sobey.   

Abstract

BACKGROUND AND
PURPOSE: We postulated that some abnormalities in cerebrovascular function after subarachnoid hemorrhage (SAH) may involve underlying alterations in K(+) channel function. Thus, using pharmacological inhibitors, we assessed the influence of SAH on function of 2 types of K(+) channel in regulation of basilar artery diameter in vivo and membrane potential (E(m)) in vitro.
METHODS: Rats were injected with saline (control) or autologous blood (SAH) into the cisterna magna. Two days later, effects of vasoactive drugs on the basilar artery were examined with a cranial window preparation. Vascular responses to 4-aminopyridine (4-AP), 3-aminopyridine (3-AP), tetraethylammonium (TEA), serotonin, acetylcholine, and adenosine were compared in control and SAH rats. Additional studies using intracellular microelectrodes evaluated the effects of 4-AP and serotonin on E(m) of basilar arteries isolated from control and SAH rats.
RESULTS: Baseline artery diameter was 236+/-5 micrometer in control rats and 220+/-7 micrometer in SAH rats (P:<0. 05). 4-AP, but not 3-AP, constricted the basilar artery in control rats, and responses to 4-AP were reduced in SAH rats. Constrictor responses to TEA or serotonin were unaffected by SAH. Vasodilator responses to acetylcholine were impaired in SAH rats, whereas responses to adenosine were not different. Resting E(m) was -81+/-3 mV in control arteries and -79+/-3 mV in SAH arteries. Both 4-AP and serotonin depolarized the basilar artery, but only 4-AP-induced depolarization was impaired in SAH arteries.
CONCLUSIONS: These data suggest that 4-AP induces cerebral vasoconstriction in vivo through smooth muscle depolarization due to inhibition of voltage-dependent K(+) channels. Furthermore, function of these K(+) channels may be selectively reduced in the basilar artery after SAH and thus could contribute to cerebral vascular dysfunction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11022080     DOI: 10.1161/01.str.31.10.2460

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Reduced Ca2+ spark activity after subarachnoid hemorrhage disables BK channel control of cerebral artery tone.

Authors:  Masayo Koide; Matthew A Nystoriak; Gayathri Krishnamoorthy; Kevin P O'Connor; Adrian D Bonev; Mark T Nelson; George C Wellman
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

2.  SAH-induced suppression of voltage-gated K(+) (K (V)) channel currents in parenchymal arteriolar myocytes involves activation of the HB-EGF/EGFR pathway.

Authors:  Masayo Koide; George C Wellman
Journal:  Acta Neurochir Suppl       Date:  2013

3.  Impact of subarachnoid hemorrhage on local and global calcium signaling in cerebral artery myocytes.

Authors:  Masayo Koide; Matthew A Nystoriak; Joseph E Brayden; George C Wellman
Journal:  Acta Neurochir Suppl       Date:  2011

4.  Expression and function of native potassium channel [K(V)alpha1] subunits in terminal arterioles of rabbit.

Authors:  A Cheong; A M Dedman; D J Beech
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

Review 5.  The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Authors:  Peter Solár; Alemeh Zamani; Klaudia Lakatosová; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2022-04-11

6.  Spatiotemporal dynamics of perfusion and oximetry during ictal discharges in the rat neocortex.

Authors:  Mingrui Zhao; Hongtao Ma; Minah Suh; Theodore H Schwartz
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

7.  Temporal profile of potassium channel dysfunction in cerebrovascular smooth muscle after experimental subarachnoid haemorrhage.

Authors:  Babak S Jahromi; Yasuo Aihara; Jinglu Ai; Zhen-Du Zhang; George Weyer; Elena Nikitina; Reza Yassari; Khaled M Houamed; R Loch Macdonald
Journal:  Neurosci Lett       Date:  2008-05-10       Impact factor: 3.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.